GlassScriptPhysician profile
Neal D Shore
NPI 1265423453
$3,176,001.03
in general payments reported to CMS, 2019-2025
100 companies · $448K in 2025
The $448K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $463K · 2020: $419K · 2021: $302K · 2022: $376K · 2023: $720K · 2024: $449K · 2025: $448K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.4M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $93K · Travel and Lodging: $86K · Honoraria: $21K · Food and Beverage: $18K · Education: $205 · Debt Forgiveness: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,398,963.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $93,179.20 |
| Travel and Lodging | $85,594.79 |
| Honoraria | $21,030.00 |
| Food and Beverage | $17,837.25 |
| Education | $204.98 |
| Debt Forgiveness | $163.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sn Holdings, LLC | $442,496.27 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $329,985.66 | 2019-2025 | |
| Janssen Research & Development, LLC | $292,022.96 | 2019-2025 | Erleada |
| Pfizer INC. | $256,928.02 | 2019-2025 | |
| Photocure INC | $237,261.05 | 2019-2025 | Cysview |
| Astrazeneca Pharmaceuticals LP | $198,454.81 | 2019-2025 | Lynparza, Imfinzi, Enhertu |
| Merck Sharp & Dohme LLC | $168,397.84 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Astrazeneca Uk Limited | $142,115.66 | 2019-2025 | Lynparza, Enhertu, Truqap |
| Genzyme Corporation | $119,237.64 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $100,040.23 | 2019-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $86,386.06 | 2019-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $84,676.17 | 2021-2025 | Lutathera |
| Janssen Scientific Affairs, LLC | $59,983.47 | 2019-2025 | Erleada, Akeega |
| Janssen Global Services, LLC | $58,505.64 | 2019-2025 | Erleada, Darzalex |
| Astellas Pharma US INC | $57,531.56 | 2019-2025 | Xtandi, Padcev |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $49,155.81 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $39,028.91 | 2019-2025 | Rezum Generator |
| Myovant Sciences INC. | $33,899.42 | 2021-2022 | |
| Amgen INC. | $33,059.09 | 2019-2025 | |
| Astellas Pharma Global Development | $31,658.09 | 2019-2025 | Xtandi |
| Ferring International Center Sa | $29,680.57 | 2019-2020 | |
| Advanced Accelerator Applications | $27,218.86 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $24,693.22 | 2019-2025 | Opdivo, Krazati |
| Sumitomo Pharma America, INC. | $24,013.56 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $23,426.81 | 2020-2025 | |
| Eli Lilly and Company | $18,427.41 | 2020-2024 | |
| Tolmar Pharmaceuticals, INC. | $17,923.68 | 2019-2022 | |
| Foundation Medicine, INC. | $17,886.12 | 2019-2021 | |
| Clovis Oncology, INC. | $17,829.27 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $16,401.23 | 2019-2025 | Pylarify |
| Tolmar, INC. | $15,090.93 | 2023-2025 | Rubraca, Jatenzo |
| Integra Gpo, LLC | $11,412.50 | 2019 | |
| Abbvie INC. | $11,219.04 | 2019-2025 | Botox |
| Illumina, INC. | $9,177.93 | 2022-2023 | Oncology Testing |
| Ferring Pharmaceuticals As | $9,141.84 | 2023-2025 | Adstiladrin |
| Daiichi Sankyo INC. | $8,985.31 | 2021-2025 | |
| Telix Pharmaceuticals | $8,433.74 | 2022-2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $6,800.86 | 2020-2024 | Prolaris |
| Glaxosmithkline, LLC. | $6,499.61 | 2024-2025 | |
| Nonagen Bioscience Corp | $5,687.50 | 2022 | |
| Siemens Medical Solutions USA, INC. | $5,685.13 | 2024 | Biograph Horizon-3r |
| Novartis Pharma Ag | $4,950.00 | 2024-2025 | Pluvicto |
| Ferring Pharmaceuticals Private Limited | $4,175.00 | 2020 | |
| Orion Corporation | $3,701.00 | 2022 | |
| Ferring Sendirian Berhad | $3,340.00 | 2021 | |
| Immunomedics, INC. | $2,700.00 | 2020 | |
| Blue Earth Diagnostics | $2,599.51 | 2019-2025 | Posluma |
| Accord Healthcare, INC. | $2,473.99 | 2023-2024 | |
| Seagen INC. | $2,334.28 | 2020-2023 | Padcev |
| Exelixis INC. | $2,179.11 | 2020-2024 | Cabometyx |
| Ferring Pharmaceuticals (Asia) Co. LTD. | $1,750.00 | 2019 | |
| Verity Pharmaceuticals INC. | $1,619.01 | 2020-2025 | Trelstar |
| Bayer Healthcare LLC | $1,400.00 | 2023 | |
| Qiagen, LLC | $1,000.00 | 2022 | |
| Genentech, INC. | $602.05 | 2019-2021 | |
| Curium US LLC | $600.00 | 2025 | Detectnet |
| Janssen Pharmaceuticals, INC | $600.00 | 2021 | |
| Emd Serono, INC. | $369.31 | 2019-2024 | Bavencio |
| Coloplast Corp | $286.96 | 2019-2024 | |
| Medtronic, INC. | $225.58 | 2021-2025 | Interstim |
| Laborie Medical Technologies Corp. | $217.85 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Eisai INC. | $215.28 | 2021-2025 | |
| Aveo Pharmaceuticals, INC. | $167.18 | 2021-2025 | Fotivda |
| Rochester Medical Corporation | $165.56 | 2019-2022 | |
| Olympus America INC. | $163.40 | 2024 | |
| Dornier Medtech America, INC | $155.73 | 2021 | |
| Teleflex LLC | $119.21 | 2019-2024 | Urolift |
| Sun Pharmaceutical Industries INC. | $113.15 | 2021-2023 | Yonsa |
| Endo Pharmaceuticals INC. | $109.74 | 2020-2024 | Xiaflex |
| Medical Device Business Services, INC. | $107.92 | 2024 | |
| Antares Pharma, INC. | $107.24 | 2020-2024 | Xyosted |
| Koelis INC. | $103.45 | 2022 | |
| Tempus Ai, INC | $92.67 | 2024-2025 | Xt Cdx |
| Gilead Sciences, INC. | $78.07 | 2024 | Trodelvy |
| Astellas Pharma Europe Bv | $71.55 | 2024 | Xtandi |
| Genentech USA, INC. | $67.15 | 2019 | |
| Convatec INC. | $62.30 | 2022-2025 | |
| Acerus Pharmaceuticals Corporation | $57.44 | 2020-2021 | |
| Immunitybio, INC. | $56.07 | 2024-2025 | |
| Allergan, INC. | $53.01 | 2019-2021 | |
| Caris Mpi, INC. | $46.60 | 2025 | Mi Cancer Seek |
| Ambu INC. | $32.83 | 2021-2024 | |
| Pharmaand Gmbh | $31.13 | 2025 | Rubraca |
| 180 Medical, INC. | $27.23 | 2020 | |
| Urovant Sciences INC | $24.62 | 2022 | |
| Endo USA, INC. | $24.56 | 2025 | Xiaflex |
| Palette Life Sciences, INC. | $23.49 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.37 | 2019-2024 | |
| Abc Home Medical Supply, INC. | $20.20 | 2022 | |
| Axonics, INC. | $20.18 | 2024 | Axonics, Bulkamid |
| Avadel Specialty Pharmaceuticals, LLC | $18.22 | 2019 | |
| Edap Technomed INC | $13.61 | 2020 | |
| Angiodynamics, INC. | $13.22 | 2020 | |
| Coherus Oncology, INC. | $12.15 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $12.05 | 2019 | |
| Clarus Therapeutics INC. | $10.32 | 2021 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$283,153.64 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$7,792,255.98 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Shore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.